Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04316169
Title Hydroxychloroquine, Abemaciclib and Endocrine Therapy in Hormone Receptor Positive (HR+)/Her 2 Negative Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Medical College of Wisconsin

Her2-receptor negative breast cancer

Advanced Solid Tumor


Abemaciclib + Anastrozole + Hydroxychloroquine

Abemaciclib + Fulvestrant + Hydroxychloroquine

Abemaciclib + Hydroxychloroquine

Abemaciclib + Hydroxychloroquine + Letrozole

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST